A new approach to antibody drug development is helping to optimise these treatments. Researchers at the Department of Biosystems Science and Engineering at ETH Zurich in Basel are using machine learning methods to help them find antibodies that better meet the requirements placed on them, such as ensuring they are better tolerated by the body.
Source: Designing better antibody drugs with artificial intelligence | EurekAlert! Science News
DEEP STATE WATCHDAWGS™©® NEWS & MEDIA SHARING GOVERNMENT OVERSIGHT ORGANIZATION 